The board of directors of I-Mab has appointed Mr. Joseph Skelton to serve as the Chief Financial Officer of the Company, effective February 5, 2024, succeeding Mr. Richard Yeh, who resigned from the Board and his executive positions with the Company. Mr. Skelton brings nearly ten years of experience in investment banking and has advised on transactions with an aggregate transaction value of more than USD 20 billion. Mr. Skelton most recently served as a Senior Vice President at Truist Securities covering the biopharma sector and previously held roles at Cantor Fitzgerald and Amneal Pharmaceuticals.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.805 USD | +0.28% | 0.00% | -5.26% |
Apr. 18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
Apr. 15 | I-Mab Announces Chief Medical Officer Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.26% | 145M | |
+26.51% | 661B | |
+27.49% | 566B | |
-6.35% | 352B | |
+20.41% | 332B | |
+3.48% | 283B | |
+14.38% | 231B | |
+5.26% | 200B | |
-8.96% | 195B | |
-4.87% | 145B |
- Stock Market
- Equities
- IMAB Stock
- News I-Mab
- I-Mab Announces Chief Financial Officer Changes